Optimizing Surgical Decisions in Young Adults With Breast Cancer

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-44
SponsorWeill Medical College of Cornell University

About this trial

The goal of this study is to understand and improve the breast surgical decision-making process for young women newly diagnosed with breast cancer. As part of this study, the investigators will evaluate the impact and use a web-based tool called CONSYDER that is designed to provide useful information to young breast cancer patients. It is also meant to improve communication between young women and their surgeons with the purpose of helping patients make appropriate surgical decisions.

Participants will complete surveys approximately within 1 week of the surgical consult and approximately 6 months after surgery. Patients who receive neoadjuvant chemotherapy will also be surveyed after the completion of neoadjuvant treatment but prior to surgery. Some patients will be invited for an interview after their surgery as part of the evaluation. A subset of patients/surgeons will also have their surgical consultation audio-recorded.

Eligibility criteria

Qualifiers

Female aged 18-44

New diagnosis of Stage 0, 1, 2, or 3 unilateral breast cancer

English or Spanish speaking

Disqualifiers

Diagnosis of de novo Stage 4 breast cancer

Recurrent early-stage breast cancer

Bilateral breast cancer

Trial design

Treatments tested in this trial

  • CONSYDER decision aid

Treatment groups

800 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Weill Medical College of Cornell University

Lead sponsor

National Institutes of Health (NIH)

Collaborator

National Cancer Institute (NCI)

Collaborator